Clinical Study of TQB2934 Injection in Relapsed/Refractory Multiple Myeloma

NCT07569757 · clinicaltrials.gov ↗

PHASE3

Phase

NOT_YET_RECRUITING

Status

260

Enrollment

INDUSTRY

Sponsor class

Conditions

Multiple Myeloma

Interventions

DRUG: TQB2934 injection
DRUG: Pomalidomide Capsule
DRUG: Selinexor tablets
DRUG: Dexamethasone tablets

Sponsor

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.